Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature assets are not reflective of its current capabilities. Recursion probably needs to advance 5-10 ...
Ph. D., George Washington University (Mathematics, Valentina Harizanov) M. S., University of Sofia, Bulgaria (Mathematical Logic and its Applications, Dimiter Skordev) Research: My research is in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback